SCYX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SCYXScynexis Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SCYXScynexis Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SCYX: latest quarter not drawable.Method ›

Price

rebased to 0%

SCYX, solidLLY, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SCYX 4

—Merckunlistedsupplier

—GlaxoSmithKline Intellectual Property (No. 3) Limited (GSK)unlistedcustomer

—Hansohunlistedcustomer

—R-Pharmunlistedcustomer

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

SCYXScynexis Inc

3.93▲+3.22%· post 3.93

Mkt cap$39.2MRevenue$235,000Q2 FY26Revenue$21MFY25

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

ClosedNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 3 '26

SCYXScynexis Inc

LLYELI Lilly & Co

3.93▲+3.22%post 3.93

Price

1,407.25▼−0.27%post 1,416.42

$39.2M

Mkt cap

$1.3T

Q2 FY26$235,000

Revenue

$24.4BQ3 FY26

FY25$21M

Revenue

$65.2BFY25

SCYX3.93▲+3.22%vsLLY1,407.25▼−0.27%ClosedNov 3 '26